Welcome to our dedicated page for Enova International SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enova International's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enova International's regulatory disclosures and financial reporting.
Enova International Executive Chairman David Fisher received a grant of 8,979 non-qualified stock options with a limited stock appreciation right (SAR) on May 13, 2026. The options have an exercise price of $166.88 per share and expire on May 13, 2033.
The award vests in three substantially equal annual installments on May 13 of 2027, 2028 and 2029, contingent on continued employment. The tandem SAR can only be exercised following a defined change in control and is payable only if a qualifying offer for Enova is made.
Enova International, Inc. reported that Chief Executive Officer Steven E. Cunningham received a grant of 10,674 non-qualified stock options with a tandem stock appreciation right. The options carry an exercise price of $166.88 per share and are exercisable for Enova common stock.
The options vest in substantially equal one-third increments on May 13, 2027, May 13, 2028, and May 13, 2029, contingent on continued employment. The award, including the limited stock appreciation right, expires on May 13, 2033 and represents compensation, not an open-market share purchase or sale.
FEEHAN DANIEL R reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Daniel R. Feehan reported new equity compensation in the form of Restricted Stock Units (RSUs). He received a grant of 1,320 shares of common stock at $0.0000 per share as a grant or award. According to the terms, 100% of these RSUs will vest on May 13, 2027, as long as he continues to serve on Enova International, Inc.’s board of directors through that date.
Following this grant, Feehan holds 61,706 shares of Enova common stock directly. He also reports indirect ownership through trusts, including 5,121 shares held by the Feehan Marital Exempt Trust, 80,325 shares held by the Feehan Marital Non-Exempt Trust, and 140,523 shares held by the Feehan Family Trust. The filing does not show any open-market purchases or sales; it mainly reflects this board-related RSU award and the updated share totals.
TEBBE MARK reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Mark Tebbe received a grant of 1,320 shares of common stock in the form of Restricted Stock Units (RSUs). The RSUs will vest in full on May 13, 2027, provided he continues to serve on Enova’s board of directors through that date.
Following this equity award, Tebbe directly holds 70,029 shares of Enova common stock. This grant functions as stock-based compensation, aligning his interests with shareholders by tying additional ownership to ongoing board service.
CARNAHAN ELLEN reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Ellen Carnahan reported an equity award and updated her share holdings. She received a grant of 1,320 shares of common stock in the form of Restricted Stock Units at an effective price of $0.00 per share.
The footnote states that 100% of these RSUs will vest on May 13, 2027, provided she continues to serve on Enova International’s board of directors through that date. Following this award, she directly holds 59,704 shares of common stock and indirectly holds 4,590 shares through the Ellen Carnahan Revocable Living Trust.
Enova International reported that its General Counsel and Secretary, Sean Rahilly, received a grant of 2,108 non-qualified stock options with a limited stock appreciation right, exercisable for common stock at an exercise price of $166.88 per share. The options were granted as compensation and vest in three substantially equal installments on May 13, 2027, May 13, 2028, and May 13, 2029, subject to continued employment. The tandem SAR becomes exercisable only after a qualifying change in control and qualifying offer, and then only for the 30-day period following such change, providing a cash-settlement feature based on the excess of the offer value over the option exercise price.
Enova International, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Of 24,945,366 common shares entitled to vote, 22,823,203 were represented in person or by proxy. Stockholders elected eleven directors to one-year terms ending at the 2027 annual meeting.
Investors also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers. In addition, they ratified the appointment of Deloitte & Touche LLP as Enova’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Enova International Executive Chairman David Fisher sold shares in an open-market transaction. On May 7, 2026, he sold 20,000 shares of common stock at a weighted average price of $173.1784 per share, in multiple trades between $172.00 and $174.18. Following this sale, Fisher directly holds 306,444 Enova shares, indicating he retained a substantial equity position after the transaction.
Enova International filed a Form 144 reporting an affiliate sale notice for Common Stock. The filing lists 20,000 shares associated with Merrill Lynch as the broker-dealer and shows total outstanding common shares of 24,884,896 as of 05/07/2026. The filing also records prior transactions, including a sale of 7,143 shares by David Fisher on 02/18/2026 for $1,067,510.49. The excerpt lists earlier stock-bonus share entries of 11,237 (02/08/2023) and 8,763 (02/06/2024).
Enova International CEO Steven E. Cunningham reported an exercise-and-sell stock transaction. He exercised non-qualified stock options for 3,696 shares of common stock at an exercise price of $31.98 per share on April 28, 2026. On the same date, he sold a total of 7,852 shares of common stock in open-market transactions at a price of $175.50 per share. After these trades, he directly owns 122,945 shares of Enova common stock and holds 7,391 non-qualified stock options with an exercise price of $31.98 per share that are scheduled to expire on August 3, 2028.